Literature DB >> 25937281

Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.

Florian T Merkle1, Werner M Neuhausser2, David Santos3, Eivind Valen4, James A Gagnon5, Kristi Maas2, Jackson Sandoe6, Alexander F Schier7, Kevin Eggan8.   

Abstract

The CRISPR-Cas9 system has the potential to revolutionize genome editing in human pluripotent stem cells (hPSCs), but its advantages and pitfalls are still poorly understood. We systematically tested the ability of CRISPR-Cas9 to mediate reporter gene knockin at 16 distinct genomic sites in hPSCs. We observed efficient gene targeting but found that targeted clones carried an unexpectedly high frequency of insertion and deletion (indel) mutations at both alleles of the targeted gene. These indels were induced by Cas9 nuclease, as well as Cas9-D10A single or dual nickases, and often disrupted gene function. To overcome this problem, we designed strategies to physically destroy or separate CRISPR target sites at the targeted allele and developed a bioinformatic pipeline to identify and eliminate clones harboring deleterious indels at the other allele. This two-pronged approach enables the reliable generation of knockin hPSC reporter cell lines free of unwanted mutations at the targeted locus.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25937281      PMCID: PMC5533178          DOI: 10.1016/j.celrep.2015.04.007

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  49 in total

Review 1.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

2.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

3.  Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors.

Authors:  Xiaoling Wang; Yebo Wang; Xiwei Wu; Jinhui Wang; Yingjia Wang; Zhaojun Qiu; Tammy Chang; He Huang; Ren-Jang Lin; Jiing-Kuan Yee
Journal:  Nat Biotechnol       Date:  2015-01-19       Impact factor: 54.908

4.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.

Authors:  Seung Woo Cho; Sojung Kim; Jong Min Kim; Jin-Soo Kim
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

Review 5.  Opportunities and challenges of pluripotent stem cell neurodegenerative disease models.

Authors:  Jackson Sandoe; Kevin Eggan
Journal:  Nat Neurosci       Date:  2013-06-25       Impact factor: 24.884

6.  Gene conversion tracts from double-strand break repair in mammalian cells.

Authors:  B Elliott; C Richardson; J Winderbaum; J A Nickoloff; M Jasin
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

Authors:  Peter Reinhardt; Benjamin Schmid; Lena F Burbulla; David C Schöndorf; Lydia Wagner; Michael Glatza; Susanne Höing; Gunnar Hargus; Susanna A Heck; Ashutosh Dhingra; Guangming Wu; Stephan Müller; Kathrin Brockmann; Torsten Kluba; Martina Maisel; Rejko Krüger; Daniela Berg; Yaroslav Tsytsyura; Cora S Thiel; Olympia-Ekaterini Psathaki; Jürgen Klingauf; Tanja Kuhlmann; Marlene Klewin; Heiko Müller; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

8.  Gene targeting in a HUES line of human embryonic stem cells via electroporation.

Authors:  Katherine M Ruby; Binhai Zheng
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

9.  GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases.

Authors:  Shengdar Q Tsai; Zongli Zheng; Nhu T Nguyen; Matthew Liebers; Ved V Topkar; Vishal Thapar; Nicolas Wyvekens; Cyd Khayter; A John Iafrate; Long P Le; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-12-16       Impact factor: 54.908

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more
  60 in total

1.  Simultaneous reprogramming and gene editing of human fibroblasts.

Authors:  Sara E Howden; James A Thomson; Melissa H Little
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

Review 2.  A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research.

Authors:  Joseph M Miano; Qiuyu Martin Zhu; Charles J Lowenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-21       Impact factor: 8.311

3.  Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.

Authors:  Yan Zhou; Yong Liu; Dianna Hussmann; Peter Brøgger; Rasha Abdelkadhem Al-Saaidi; Shuang Tan; Lin Lin; Trine Skov Petersen; Guang Qian Zhou; Peter Bross; Lars Aagaard; Tino Klein; Sif Groth Rønn; Henrik Duelund Pedersen; Lars Bolund; Anders Lade Nielsen; Charlotte Brandt Sørensen; Yonglun Luo
Journal:  Cell Mol Life Sci       Date:  2016-01-11       Impact factor: 9.261

Review 4.  From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering.

Authors:  Rebecca K Delker; Richard S Mann
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.

Authors:  Joseph C Giacalone; Tasneem P Sharma; Erin R Burnight; John F Fingert; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2018-02-28

Review 6.  Kidney organoids in translational medicine: Disease modeling and regenerative medicine.

Authors:  Tomoya Miyoshi; Ken Hiratsuka; Edgar Garcia Saiz; Ryuji Morizane
Journal:  Dev Dyn       Date:  2019-03-26       Impact factor: 3.780

Review 7.  CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration.

Authors:  Erin R Burnight; Joseph C Giacalone; Jessica A Cooke; Jessica R Thompson; Laura R Bohrer; Kathleen R Chirco; Arlene V Drack; John H Fingert; Kristan S Worthington; Luke A Wiley; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Prog Retin Eye Res       Date:  2018-03-22       Impact factor: 21.198

8.  Healing a Heart Through Genetic Intervention.

Authors:  Jeanne James; Jeffrey Robbins
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

Review 9.  Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.

Authors:  William T Hendriks; Curtis R Warren; Chad A Cowan
Journal:  Cell Stem Cell       Date:  2016-01-07       Impact factor: 24.633

10.  The CRISPR/Cas9 system for gene editing and its potential application in pain research.

Authors:  Linlin Sun; Brianna Marie Lutz; Yuan-Xiang Tao
Journal:  Transl Perioper Pain Med       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.